Sanofi-Aventis Acquisitions Could Double OTC Sales By 2014
This article was originally published in The Tan Sheet
Executive Summary
French drug maker Sanofi-Aventis is establishing an OTC division and plans to double revenues from nonprescription drug products within five years
You may also be interested in...
Sanofi Board Forces Out CEO Chris Viehbacher Amid Lantus Woes
Sanofi announced that Christopher Viehbacher has resigned as CEO after its board voted unanimously to remove him. The drama comes amid serious worries over the group’s cash cow medicine, Lantus.
Sanofi Board Forces Out CEO Chris Viehbacher Amid Lantus Woes
Sanofi announced that Christopher Viehbacher has resigned as CEO after its board voted unanimously to remove him. The drama comes amid serious worries over the group’s cash cow medicine, Lantus.
People In Brief
Colgate appoints new CFO